V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029928 | 20085762 | 1.73 | 78.4 | 03 | 2020-02-03 | 2020-02-04 | Doxorubicin + Olaratumab | Y | N | ALECTINIB | 101801429 |
| 20029942 | 20085763 | 1.71 | 97.5 | Palliative (P) | 2017-02-16 | 2017-03-24 | Capecitabine+Cisplatin+Streptozocin | 02 | N | RALTITREXED | 101522521 |
| 20029972 | 20085764 | 1.71 | 77.8 | Palliative (P) | 2016-05-14 | 2016-06-09 | ARISTOTLE TRIAL | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100414704 |
| 20030048 | 20085765 | 1.88 | 76.4 | Palliative (P) | 2016-12-17 | 2016-12-23 | EC | 2 | N | ACELARATE TRIAL | 100146920 |
| 20030088 | 20085766 | 1.73 | 64.1 | Palliative (P) | 2019-02-15 | 2019-02-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | MIC | 101631956 |
| 20030124 | 20085767 | 1.94 | 56.7 | Palliative (P) | 2018-03-15 | 2018-03-30 | CISPLATIN + FLUOROURACIL + MITOMYCIN | 02 | Y | MITOMYCIN | 101223043 |
| 20030132 | 20085768 | 1.66 | 55.8 | Neo-adjuvant (N) | 2019-01-09 | 2019-01-09 | Temozolomide + RT | 01 | N | CAPECITABINE + STREPTOZOCIN | 100287859 |
| 20030177 | 20085769 | null | 62.2 | Palliative (P) | 2018-12-11 | 2018-12-11 | PRICKLE trial | 02 | Y | MPV | 101322671 |
| 20030219 | 20085770 | 1.75 | 118.2 | Palliative (P) | 2018-03-02 | 2018-03-17 | MITOMYCIN | 02 | null | PEMBROLIZUMAB | 101791800 |
| 20030288 | 20085772 | 1.72 | 78.4 | Curative (C) | 2016-12-09 | 2016-12-19 | SCOPE 2 TRIAL | 02 | N | TEMOZOLOMIDE | 100621663 |
| 20030320 | 20085773 | 1.69 | 70.25 | Palliative (P) | 2021-01-26 | 2021-02-22 | CAPECITABINE + CARBOPLATIN + Trastuzumab | 02 | null | CISPLATIN + VINORELBINE | 100762275 |
| 20030427 | 20085775 | 1.76 | 53.1 | Palliative (P) | 2016-11-04 | 2016-11-06 | ECarboX | 02 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100460397 |
| 20030452 | 20085776 | null | 77.9 | Neo-adjuvant (N) | 2016-03-29 | 2016-03-31 | PEMBROLIZUMAB | 02 | N | BORTEZOMIB + THALIDOMIDE | 101210463 |
| 20030480 | 20085777 | 1.65 | 49.2 | 03 | 2018-04-14 | 2018-04-14 | Panitumumab | 01 | N | NIVOLUMAB | 100324300 |
| 20030507 | 20085778 | 1.53 | 89 | 03 | 2019-07-31 | 2019-08-15 | Ixazomib + Lenalidomide | 02 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100510614 |
| 20030585 | 20085780 | 1.73 | 78 | null | null | 2016-03-16 | PEMBROLIZUMAB | N | Y | FCARBOST | 101623126 |
| 20030713 | 20085781 | 1 | 86 | null | 2017-10-08 | 2017-10-27 | EVEROLIMUS | N | N | CISPLATIN + FU + TRASTUZUMAB | 101581911 |
| 20030738 | 20085782 | 1.75 | 62.2 | null | 2021-10-27 | 2021-10-27 | Capital Trial | 02 | Y | OXALIPLATIN | 100372454 |
| 20030768 | 20085783 | 0 | 51 | Adjuvant (A) | 2018-11-17 | 2018-11-17 | Irinotecan | 01 | N | BACILLUS CALMETTE-GUERIN | 101644629 |
| 20030796 | 20085784 | 1.7 | 71.5 | 03 | 2018-02-05 | 2018-02-18 | null | 02 | N | GC INT GUIDE EXCRANIAL GERMCELL JEB | 101274875 |
| 20030804 | 20085785 | 1.79 | 59.8 | 03 | null | 2019-09-19 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN + PEMETREXED | 101523003 |
| 20030825 | 20085786 | 1.72 | 78.6 | Adjuvant (A) | 2018-05-14 | 2018-05-16 | ESPAC-4 TRIAL | 02 | Y | EVEROLIMUS | 100144089 |
| 20030834 | 20085787 | 1.62 | 65.5 | 03 | 2018-05-20 | 2018-05-26 | ARISTOTLE TRIAL | 02 | N | IPILIMUMAB + NIVOLUMAB | 101351524 |
| 20030858 | 20085789 | 1.71 | 55 | Palliative (P) | 2017-07-05 | 2017-07-22 | POMALIDOMIDE | 02 | N | BALLAD TRIAL | 100702953 |
| 20030888 | 20085791 | null | null | Palliative (P) | 2016-12-28 | 2017-01-23 | ARISTOTLE TRIAL | 02 | Y | NAB-PACLITAXEL | 100665955 |
| 20030892 | 20085792 | 1.55 | 65.6 | Palliative (P) | 2016-10-13 | 2016-10-19 | Panitumumab | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101321274 |
| 20030907 | 20085793 | 0 | 0 | Curative (C) | 2016-12-26 | 2017-01-05 | BCG Intravesical | 02 | N | IBRUTINIB | 101198752 |
| 20030926 | 20085794 | 1.78 | 81.8 | 03 | 2017-07-10 | 2017-07-30 | Docetaxel | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100920460 |
| 20030944 | 20085795 | 1.69 | 69.9 | 03 | 2016-08-02 | 2016-08-02 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | CARBOPLATIN + FLUOROURACIL | 100024182 |
| 20031032 | 20085797 | 0 | 0 | 03 | 2020-03-14 | 2020-03-21 | Panitumumab | null | N | NOT MATCHED | 100832197 |
| 20031055 | 20085798 | 1.67 | 43.6 | Palliative (P) | 2018-04-28 | 2018-05-10 | MITOMYCIN | 02 | N | BORTEZOMIB + THALIDOMIDE | 101625207 |
| 20031078 | 20085799 | 1.78 | 62.8 | 03 | 2018-01-25 | 2018-01-25 | CHOP R | 02 | N | CARBO + FLUOROURACIL | 101078781 |
| 20031086 | 20085800 | 1.98 | 103 | Palliative (P) | 2018-12-21 | 2018-12-31 | CAP + RT | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100715511 |
| 20031112 | 20085801 | 1.72 | 77.4 | Palliative (P) | null | 2016-07-15 | ACELARATE Trial | Y | N | HEP HR HEPATOBLASTOMA GUIDE CISP | 100497654 |
| 20031129 | 20085802 | 1.81 | 69.75 | null | 2016-05-05 | 2016-05-05 | null | null | N | OXALIPLATIN + MDG + PANITUMUMAB | 101493793 |
| 20031138 | 20085803 | 1.54 | 96 | Neo-adjuvant (N) | 2016-07-31 | 2016-08-20 | CARBOPLATIN + FLUOROURACIL | 02 | N | EVEROLIMUS | 100388907 |
| 20031149 | 20085804 | 1.72 | 62 | Palliative (P) | 2015-04-10 | 2015-04-15 | FCarboSt | 02 | N | CHOP R | 101816221 |
| 20031175 | 20085805 | 1.01 | 56.4 | null | null | 2017-09-29 | ESPAC-4 TRIAL | null | N | ACTICCA-1 TRIAL | 101670634 |
| 20031186 | 20085806 | 1.75 | 73.6 | 03 | null | 2020-03-16 | PACLITAXEL | N | N | EOF | 100110835 |
| 20031195 | 20085807 | 1.66 | 53.3 | Palliative (P) | 2017-12-29 | 2018-01-21 | CAP + RT | 01 | N | MITOMYCIN | 100173461 |
| 20031197 | 20085808 | 1.78 | 43.8 | Adjuvant (A) | 2018-08-15 | 2018-08-27 | EVEROLIMUS | N | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101805692 |
| 20031201 | 20085809 | 1.74 | 95 | Palliative (P) | 2020-04-07 | 2020-04-13 | HEP SIOPEL 6 Cisplatin | N | Y | GO2 TRIAL | 100863768 |
| 20031243 | 20085810 | 1.77 | 53.6 | 03 | 2019-08-19 | 2019-08-22 | HEP SIOPEL 6 Cisplatin | 02 | N | CARBOPLATIN + EPIRUBICIN + FLUOROURACIL | 101733533 |
| 20031263 | 20085812 | null | 71.6 | 03 | 2017-01-04 | 2017-01-20 | Hepatoblastoma SR Cisplatin | N | N | IRINOTECAN + MDG + PANITUMUMAB | 101564640 |
| 20031268 | 20085813 | 1.74 | 84.4 | Palliative (P) | 2019-04-04 | 2019-04-04 | ECarboX | 02 | N | SUNITINIB | 100294143 |
| 20031322 | 20085814 | 1.77 | 51.5 | Adjuvant (A) | 2020-02-22 | 2020-02-23 | DARATUMUMAB | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100206758 |
| 20031368 | 20085815 | 1.79 | 103 | Palliative (P) | 2017-09-28 | 2017-09-28 | FOXTROT TRIAL | 02 | N | GEMCITABINE + OXALIPLATIN | 100699704 |
| 20031434 | 20085816 | null | 88.1 | Adjuvant (A) | null | 2016-01-24 | CARBO + FLUOROURACIL | 1 | N | RUXOLITINIB | 100336337 |
| 20031493 | 20085817 | 1.82 | 76.7 | Palliative (P) | 2018-05-27 | 2018-05-27 | CARBOPLATIN + FLUOROURACIL | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 101188149 |
| 20031498 | 20085818 | 1.7 | 66.05 | null | 2016-12-09 | 2016-12-09 | Docetaxel 75mg/m2 (21 day) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101338055 |